Search Results - "Yeh, Rosa F"

Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women by YEH, Rosa F, REZK, Naser L, PATTERSON, Kristine B, KASHUBA, Angela D. M, DUMOND, Julie B, TAPPOUNI, Hiba L, TIEN, Hsiao-Chuan, CHEN, Ya-Chi, VOURVAHIS, Manoli, HORTON, Amanda L, FISCUS, Susan A

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Impact of Sample Size on the Performance of Multiple-Model Pharmacokinetic Simulations by TAM, Vincent H, KABBARA, Samer, YEH, Rosa F, LEARY, Robert H

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa by Khandelwal, Pooja, Yeh, Rosa F., Yu, Louie, Lane, Adam, Dandoy, Christopher E., El-Bietar, Javier, Davies, Stella M., Grimley, Michael S.

“…INTRODUCTION:We hypothesized that the addition of 4 doses of abatacept to our standard acute graft versus host disease (GVHD) prophylaxis would reduce the…”
Get full text

Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer by Rodler, Eve T, Kurland, Brenda F, Griffin, Melissa, Gralow, Julie R, Porter, Peggy, Yeh, Rosa F, Gadi, Vijayakrishna K, Guenthoer, Jamie, Beumer, Jan H, Korde, Larissa, Strychor, Sandra, Kiesel, Brian F, Linden, Hannah M, Thompson, John A, Swisher, Elizabeth, Chai, Xiaoyu, Shepherd, Stacie, Giranda, Vincent, Specht, Jennifer M

“…Cisplatin is synergistic with vinorelbine and the PARP inhibitor veliparib, and has antineoplastic activity in triple-negative breast cancer (TNBC) and BRCA…”
Get full text

Significant publications on infectious diseases pharmacotherapy in 2009 by Palmer, Hannah R, Cottreau, Jessica M, Garey, Kevin W, Hirsch, Elizabeth B, Musick, William L, Tam, Vincent H, Yeh, Rosa F

“…Significant publications on infectious diseases (ID) pharmacotherapy in 2009 are summarized. On December 31, 2009, the Houston Infectious Diseases Network…”
Get full text

Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians by Birtcher, Kimberly K, Corbett, Stephanie Mallow, Pass, Steven E, Coyle, Elizabeth A, Yeh, Rosa F, Tipton, Joyce, Garey, Kevin W

“…The findings of an academic symposium as they relate to the history and role of the academic pharmacy clinician, the strengths and limitations of the academic…”
Get full text

Quality Control of Busulfan Plasma Quantitation, Modeling, and Dosing: An Interlaboratory Proficiency Testing Program by McCune, Jeannine S., Punt, Arjen M., Yeh, Rosa F., Dupuis, L. Lee, Kweekel, Dina M., Franssen, Eric J. F., Ritchie, James C., van Maarseveen, Erik, Huitema, Alwin D. R.

“…Personalizing busulfan doses to target a narrow plasma exposure has improved the efficacy and lowered the toxicity of busulfan-based conditioning regimens used…”
Get full text

Antiretroviral drug exposure in the female genital tract : implications for oral pre-and post-exposure prophylaxis by DUMOND, Julie B, YEH, Rosa F, PATTERSON, Kristine B, CORBETT, Amanda H, JUNG, Byung Hwa, REZK, Naser L, BRIDGES, Arlene S, STEWART, Paul W, COHEN, Myron S, KASHUBA, Angela D. M

“…To describe first dose and steady state antiretroviral drug exposure in the female genital tract. Non-blinded, single center, open-label pharmacokinetic study…”
Get full text

Significant publications on infectious diseases pharmacotherapy in 2007 by Yeh, Rosa F, Kuper, Kristi M, Coyle, Elizabeth A, Garey, Kevin W, Ikwuagwu, Judy O, Maclayton, Darego O, Mohr, John F, Musick, William L, Pass, Steven E, Rios, Edgar, Tam, Vincent H

“…Significant publications on infectious diseases (ID) pharmacotherapy in 2007 were compiled and summarized. On January 2, 2008, the 21 members of the Houston…”
Get full text

Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers by Yeh, Rosa F, Gaver, Vincent E, Patterson, Kristine B, Rezk, Naser L, Baxter-Meheux, Faustina, Blake, Michael J, Eron, Joseph J, Klein, Cheri E, Rublein, John C, Kashuba, Angela D.M

“…OBJECTIVE:The effect of lopinavir/ritonavir (LPV/r) administration on cytochrome P450 (CYP) enzyme activity was quantified using a phenotyping biomarker…”
Get full text

Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring by REZK, Naser L, CRUTCHLEY, Rustin D, YEH, Rosa F, KASHUBA, Angela D. M

“…Because HIV medications are used in combination, it is important to develop multiplex assays to streamline the therapeutic drug monitoring process and provide…”
Get full text

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting by Yeh, Rosa F, Jain, Rupali, Palmer, Hannah R

“…The meeting of the American Society of Microbiology was recently held in San Francisco, CA, USA - a gathering of experts in the fields of infectious diseases,…”
Get more information

Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients by Ajuoga, Elizabeth, Sansgiry, Sujit S., Ngo, Caroline, Yeh, Rosa F.

“…Self-medication practices and polypharmacy are common among human immunodeficiency virus (HIV)-infected patients. Inappropriate use of over-the-counter (OTC)…”
Get full text

Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement by McCune, Jeannine S., Quinones, Christine M., Ritchie, James, Carpenter, Paul A., van Maarseveen, Erik, Yeh, Rosa F., Anasetti, Claudio, Boelens, Jaap J., Hamerschlak, Nelson, Hassan, Moustapha, Kang, Hyoung Jin, Kanda, Yoshinobu, Paci, Angelo, Perales, Miguel-Angel, Shaw, Peter J., Seewaldt, Victoria L., Savani, Bipin N., Hsieh, Angela, Poon, Betsy, Mohty, Mohamad, Pulsipher, Michael A., Pasquini, Marcelo, Dupuis, L. Lee

“…•Five busulfan plasma exposure units (BPEUs) are used currently.•We used the Delphi consensus method to harmonize to 1 BPEU for international use.•There was…”
Get full text

The association of pharmacy drug-delivery services with adherence in an urban HIV population by Yeh, Rosa F., Gupta, Shailendra A., Sangani, Darshan N., Sansgiry, Sujit S.

“…Objective The aim of this study was to examine the effect of drug‐distribution methods on antiretroviral medication adherence in HIV‐positive patients. Methods…”
Get full text

Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement" by Dupuis, L. Lee, Quinones, Christine M., Ritchie, James, Carpenter, Paul A., Bauters, Tiene, Yeh, Rosa F., Anasetti, Claudio, Boelens, Jaap J., Hamerschlak, Nelson, Hassan, Moustapha, Kang, Hyoung Jin, Kanda, Yoshinobu, Paci, Angelo, Perales, Miguel-Angel, Shaw, Peter J., Seewaldt, Victoria L., Savani, Bipin N., Militano, Olga, Pulsipher, Michael A., McCune, Jeannine S.

Get full text

Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients by Yeh, Rosa F, Pawlikowski, Matthew A, Blough, David K, McDonald, George B, O’Donnell, Paul V, Rezvani, Andrew, Deeg, H. Joachim, McCune, Jeannine S

“…Daily intravenous (i.v.) busulfan is increasingly being used in hematopoietic cell transplantation (HCT) conditioning regimens. Intravenous busulfan doses…”
Get full text

Impact of Over-the-Counter Medication Misuse and Adverse Drug Events on HIV Patients' Health-Related Quality of Life by Sansgiry, Sujit S, Ajuoga, Elizabeth, Ngo, Caroline, Yeh, Rosa F

“…Background: Over-the-counter (OTC) medication use has increased among HIV-infected patients. Inappropriate use of OTC drugs may increase the risk of potential…”
Get full text

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes by Flowers, Christopher R, Costa, Luciano J, Pasquini, Marcelo C, Le-Rademacher, Jennifer, Lill, Michael, Shore, Tsiporah B, Vaughan, William, Craig, Michael, Freytes, Cesar O, Shea, Thomas C, Horwitz, Mitchell E, Fay, Joseph W, Mineishi, Shin, Rondelli, Damiano, Mason, James, Braunschweig, Ira, Ai, Weiyun, Yeh, Rosa F, Rodriguez, Tulio E, Flinn, Ian, Comeau, Terrance, Yeager, Andrew M, Pulsipher, Michael A, Bence-Bruckler, Isabelle, Laneuville, Pierre, Bierman, Philip, Chen, Andy I, Kato, Kazunobu, Wang, Yanlin, Xu, Cong, Smith, Angela J, Waller, Edmund K

“…Abstract Busulfan, cyclophosphamide, and etoposide (BuCyE) is a commonly used conditioning regimen for autologous stem cell transplantation (ASCT). This…”
Get full text

Lopinavir/ritonavir dosage form affects quality of life during monotherapy in HIV-positive adults by Yeh, Rosa F, Lipman, Bryan A, Mayberry, Carl, Miguel, Bernie, Nemecek, John J, Gathe, Jr, Joseph C

“…This was a single-center, open-label study of lopinavir/ritonavir (LPV/r) single-agent therapy in antiretroviral-naive, HIV-infected participants initiating…”
Get full text